(VIANEWS) – Pinduoduo (PDD), Exelixis (EXEL), Stryker Corp (SYK) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Pinduoduo (PDD)
56.6% sales growth and 34.92% return on equity
PDD Holdings Inc., a multinational commerce group, owns and operates a portfolio of businesses. It operates Pinduoduo, an e-commerce platform that offers products in various categories, including agricultural produce, apparel, shoes, bags, mother and childcare products, food and beverage, electronic appliances, furniture and household goods, cosmetics and other personal care, sports and fitness items and auto accessories; and Temu, an online marketplace. It focuses on bringing businesses and people into the digital economy. The company was formerly known as Pinduoduo Inc. and changed its name to PDD Holdings Inc. in February 2023. PDD Holdings Inc. was incorporated in 2015 and is based in Dublin, Ireland.
Earnings Per Share
As for profitability, Pinduoduo has a trailing twelve months EPS of $3.87.
PE Ratio
Pinduoduo has a trailing twelve months price to earnings ratio of 30.45. Meaning, the purchaser of the share is investing $30.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.92%.
Volume
Today’s last reported volume for Pinduoduo is 2726880 which is 68.93% below its average volume of 8778550.
Revenue Growth
Year-on-year quarterly revenue growth grew by 66.3%, now sitting on 165.24B for the twelve trailing months.
Yearly Top and Bottom Value
Pinduoduo’s stock is valued at $117.86 at 09:22 EST, higher than its 52-week high of $112.77.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 5.5% and positive 6.7% for the next.
2. Exelixis (EXEL)
18.4% sales growth and 3.8% return on equity
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, it is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer; XB002, an antibody-drug conjugate composed of human mAb against tissue factor (TF) for the treatment of advanced solid tumors; XL102, an orally bioavailable cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced or metastatic solid tumors; and XB002 for the treatment of non-hodgkin's lymphoma. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.
Earnings Per Share
As for profitability, Exelixis has a trailing twelve months EPS of $0.29.
PE Ratio
Exelixis has a trailing twelve months price to earnings ratio of 72.57. Meaning, the purchaser of the share is investing $72.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.8%.
Moving Average
Exelixis’s worth is under its 50-day moving average of $21.30 and higher than its 200-day moving average of $19.78.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Exelixis’s EBITDA is 3.19.
Volume
Today’s last reported volume for Exelixis is 428077 which is 81.61% below its average volume of 2328180.
3. Stryker Corp (SYK)
12.2% sales growth and 15.04% return on equity
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Earnings Per Share
As for profitability, Stryker Corp has a trailing twelve months EPS of $6.75.
PE Ratio
Stryker Corp has a trailing twelve months price to earnings ratio of 43.73. Meaning, the purchaser of the share is investing $43.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.04%.
Moving Average
Stryker Corp’s value is higher than its 50-day moving average of $275.06 and higher than its 200-day moving average of $281.09.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Sep 27, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 1.04%.
Yearly Top and Bottom Value
Stryker Corp’s stock is valued at $295.16 at 09:22 EST, under its 52-week high of $306.93 and way higher than its 52-week low of $222.66.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 9% and 18.2%, respectively.
4. Terex Corporation (TEX)
11.1% sales growth and 37.99% return on equity
Terex Corporation manufactures and sells aerial work platforms and materials processing machinery worldwide. It operates in two segments, Aerial Work Platforms (AWP) and Materials Processing (MP). The AWP segment designs, manufactures, services, and markets aerial work platform equipment, utility equipment, and telehandlers under the Terex and Genie brands. Its products comprise portable material lifts, portable aerial work platforms, trailer-mounted articulating booms, self-propelled articulating and telescopic booms, and scissor lifts, as well as related components and replacement parts for construction and maintenance of industrial, commercial, institutional, and residential buildings and facilities, utility and telecommunication lines, construction and foundation drilling applications, and other commercial operations, as well as in tree trimming and various infrastructure projects. The MP segment's materials processing and specialty equipment includes crushers, washing systems, screens, trommels, apron feeders, material handlers, pick and carry cranes, rough terrain cranes, tower cranes, wood processing, biomass and recycling equipment, concrete mixer trucks and concrete pavers, conveyors, and related components and replacement parts under the Terex, Powerscreen, Fuchs, EvoQuip, Canica, Cedarapids, CBI, Simplicity, Franna, Terex Ecotec, Finlay, ProAll, ZenRobotics, Terex Washing Systems, Terex MPS, Terex Jaques, Terex Advance, ProStack, Terex Bid-Well, MDS, and Terex Recycling Systems brand names and business lines. Its products are used in construction, infrastructure, and recycling projects; quarrying and mining, and material handling applications; maintenance applications to lift equipment or material; and landscaping and biomass production industries. The company offers financing solutions to assist customers in the rental, leasing, and acquisition of its products.Terex Corporation is based in Norwalk, Connecticut.
Earnings Per Share
As for profitability, Terex Corporation has a trailing twelve months EPS of $7.02.
PE Ratio
Terex Corporation has a trailing twelve months price to earnings ratio of 7.32. Meaning, the purchaser of the share is investing $7.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.99%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 3.7% and a drop 2.5% for the next.
Moving Average
Terex Corporation’s worth is under its 50-day moving average of $52.73 and under its 200-day moving average of $53.60.
5. Hyatt Hotels Corporation (H)
10.9% sales growth and 13.87% return on equity
Hyatt Hotels Corporation operates as a hospitality company in the United States and internationally. It operates through Owned and Leased Hotels, Americas Management and Franchising, ASPAC Management and Franchising, EAME/SW Asia Management and Franchising, and Apple Leisure Group segments. The company manages, franchises, licenses, owns, and leases portfolio of properties, consisting of full-service hotels, select service hotels, resorts, and other properties, including timeshare, fractional, residential, vacation, and condominium units. It operates its properties under the Park Hyatt, Miraval, Grand Hyatt, Alila, Andaz, The Unbound Collection by Hyatt, Destination, Hyatt Regency, Hyatt, Thompson Hotels, Hyatt Centric, Joie de Vivre, Caption by Hyatt, Hyatt House, Hyatt Place, Hyatt Ziva, Hyatt Zilara, UrCove, Hyatt Residence Club, Hyatt Residences, Hyatt Resorts, Secrets Resorts & Spas, Dreams Resorts & Spas, Breathless Resorts & Spas, Zoetry Wellness & Spa Resorts, Alua Hotels & Resorts, and Sunscape Resorts & Spas brands. As of September 30, 2022, the company's hotel portfolio consisted of approximately 1,200 hotels in 72 countries across six continents. It primarily serves corporations; national, state, and regional associations; specialty market accounts, including social, government, military, educational, religious, and fraternal organizations; travel agency and luxury organizations; and a group of individual consumers. The company also operates World of Hyatt loyalty program which rewards points that can be redeemed for hotel nights and other rewards. Hyatt Hotels Corporation was founded in 1957 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, Hyatt Hotels Corporation has a trailing twelve months EPS of $4.45.
PE Ratio
Hyatt Hotels Corporation has a trailing twelve months price to earnings ratio of 24.88. Meaning, the purchaser of the share is investing $24.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.87%.
Sales Growth
Hyatt Hotels Corporation’s sales growth is 1.6% for the present quarter and 10.9% for the next.
6. Curtiss (CW)
10.8% sales growth and 16.89% return on equity
Curtiss-Wright Corporation, together with its subsidiaries, designs, manufactures, and overhauls precision components, and engineered products and services primarily to the aerospace, defense, general industrial, and power generation markets worldwide. The company operates through three segments: Commercial/Industrial, Defense, and Power. The Commercial/Industrial segment offers industrial vehicle products, such as electronic throttle control devices, joysticks, and transmission shifters; sensors, controls and electro-mechanical actuation components used in commercial aircrafts; valves for use in the industrial markets; and surface technology services, including shot peening, laser peening, coatings, and advanced testing. The Defense segment provides commercial off-the-shelf embedded computing board-level modules, data acquisition and flight test instrumentation equipment, integrated subsystems, instrumentation and control systems, turret aiming and stabilization products, and weapons handling systems; avionics and electronics; and aircraft data management solutions to the commercial aerospace market. The Power segment offers hardware, pumps, pump seals, control rod drive mechanisms, valves, fastening systems, specialized containment doors, airlock hatches, spent fuel management products, and fluid sealing products for nuclear power plants and nuclear equipment manufacturers; and naval propulsion and auxiliary equipment, including coolant pumps, power-dense compact motors, generators, steam turbines, valves, and secondary propulsion systems, as well as ship repair and maintenance services primarily to the U.S. navy. Curtiss-Wright Corporation was founded in 1929 and is headquartered in Davidson, North Carolina.Curtiss-Wright Corporation, together with its subsidiaries, designs, manufactures, and overhauls precision components, and engineered products and services primarily to the aerospace, defense, general industrial, and power generation markets worldwide. The company operates through three segments: Commercial/Industrial, Defense, and Power. The Commercial/Industrial segment offers industrial vehicle products, such as electronic throttle control devices, joysticks, and transmission shifters; sensors, controls and electro-mechanical actuation components used in commercial aircrafts; valves for use in the industrial markets; and surface technology services, including shot peening, laser peening, coatings, and advanced testing. The Defense segment provides commercial off-the-shelf embedded computing board-level modules, data acquisition and flight test instrumentation equipment, integrated subsystems, instrumentation and control systems, turret aiming and stabilization products, and weapons handling systems; avionics and electronics; and aircraft data management solutions to the commercial aerospace market. The Power segment offers hardware, pumps, pump seals, control rod drive mechanisms, valves, fastening systems, specialized containment doors, airlock hatches, spent fuel management products, and fluid sealing products for nuclear power plants and nuclear equipment manufacturers; and naval propulsion and auxiliary equipment, including coolant pumps, power-dense compact motors, generators, steam turbines, valves, and secondary propulsion systems, as well as ship repair and maintenance services primarily to the U.S. navy. Curtiss-Wright Corporation was founded in 1929 and is headquartered in Davidson, North Carolina.
Earnings Per Share
As for profitability, Curtiss has a trailing twelve months EPS of $8.92.
PE Ratio
Curtiss has a trailing twelve months price to earnings ratio of 23.92. Meaning, the purchaser of the share is investing $23.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.89%.
7. Celestica (CLS)
6.9% sales growth and 12.27% return on equity
Celestica Inc. provides hardware platform and supply chain solutions in North America, Europe, and Asia. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services. It also provides enterprise-level data communications and information processing infrastructure products, such as routers, switches, data center interconnects, servers, and storage-related products; capacitors, microprocessors, resistors, and memory modules; and power inverters, energy storage products, smart meters, and other electronic componentry. The company serves aerospace and defense, industrial, energy, healthtech, capital equipment, original equipment manufacturers (OEMs), cloud-based, and other service providers, including hyperscalers, and other companies in a range of industries. Celestica Inc. was incorporated in 1994 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Celestica has a trailing twelve months EPS of $1.68.
PE Ratio
Celestica has a trailing twelve months price to earnings ratio of 15.25. Meaning, the purchaser of the share is investing $15.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.27%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 7.86B for the twelve trailing months.
Moving Average
Celestica’s value is above its 50-day moving average of $24.42 and way higher than its 200-day moving average of $16.97.
Yearly Top and Bottom Value
Celestica’s stock is valued at $25.62 at 09:22 EST, under its 52-week high of $27.58 and way higher than its 52-week low of $10.50.
Previous days news about Celestica(CLS)
- According to Zacks on Monday, 20 November, "Shares of Vertiv and Celestica have returned 216.9% and 148.9% on a year-to-date basis, respectively."
